SCHEMBL30435003

SCHEMBL30435003

CC1(C)OC(=O)C(=C(O)Cc2cc(F)ccc2[N+](=O)[O-])C(=O)O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 4/20 0.40
TDP1 Q9NUW8 2/20 0.40
ATM Q13315 1/20 0.40
ALDH1A1 P00352 5/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39
PTPN1 P18031 4/20 0.37
ACP1 P24666 2/20 0.37
CDC25B P30305 2/20 0.37
MAOA P21397 2/20 0.36
MAOB P27338 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28447446 1.00 SNCA (0.40) SNCATDP1ATMALDH1A1MAPT
SCHEMBL21061886 0.86 TSHR (0.42) ALDH1A1PTPN1ACP1CDC25BMAOA
SCHEMBL21061683 0.85 KMT2A (0.41) ATMALDH1A1MAPTMAPK1PTPN1
SCHEMBL28445030 0.85 PTPN1 (0.37) ALDH1A1MAPTPTPN1ACP1CDC25B
SCHEMBL21061949 0.85 HPD (0.41) TDP1ALDH1A1MAPTMAPK1CYP1A2
SCHEMBL29500904 0.85 HPD (0.41) TDP1ALDH1A1MAPTMAPK1CYP1A2
SCHEMBL21062120 0.83 ALDH1A1 (0.46) ALDH1A1MAPTMAPK1PTPN1MAOA
SCHEMBL29500903 0.83 ALDH1A1 (0.46) ALDH1A1MAPTMAPK1PTPN1MAOA
SCHEMBL8307611 0.83 PTPN1 (0.41) ALDH1A1MAPTPTPN1ACP1CDC25B
SCHEMBL29500921 0.81 TDP1 (0.40) SNCATDP1ATMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111479813-B Triazolobenzazepines as vasopressin V1A receptor antagonists 吉瑞工厂 2023-03-21 CN disclosed